PhRMA Lists NAFTA Renegotiation Priorities For Better US Exports
Executive Summary
US pharmaceutical industry association PhRMA has laid out what it thinks should be priorities in the upcoming renegotiation of the North American Free Trade Agreement. It wants pricing and reimbursement systems that reward innovation and improved enforcement of patentability standards.